Clinical trial
Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034）
NCT03735264
Study timeline
Study start (estimated)2018-11-15Date precision: day
Registry last updated2018-11-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancerunresolved
Interventions
Sponsors & collaborators
The Affiliated Hospital of Qingdao Universitylead sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.collaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03735264 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.